During study startup, clinical trials sponsors must balance study enrollment targets and expectations with the capabilities delivered by global sites. Beyond the traditional challenges that companies face with enrollment, Amgen also had to navigate issues created by the COVID-19 global pandemic that impacted daily activities and enrollment in clinical studies.
Amgen, one of the world’s largest independent biopharmaceutical companies, has adopted use of StudyTeam across their entire global research portfolio.
Reify Health provides cloud-based software that accelerates the development of new and life-saving therapies. We serve the global life science industry, including thousands of clinical research sites, the most innovative biotechs, and the world's largest biopharmaceutical companies.
Play the video to hear how StudyTeam can help you speed up enrollment.